Chemokine to the Rescue: Interleukin-8 Mediates Resistance to PI3K-Pathway-Targeted Therapy in Breast Cancer

Cancer Cell

Volumn 22, Issue 6, 2012, Pages 703-705

  Abraham, Robert T ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; INTERLEUKIN 8; JANUS KINASE 2; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGY; BREAST CANCER; CANCER RESISTANCE; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 84870832259     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.11.012     Document Type: Short Survey

References (10)

1. Bagrodia S., Smeal T., Abraham R.T. Pigment Cell Melanoma Res. 2012, 25:819-831.
2. Britschgi A., Andraos R., Brinkhaus H., Klebba I., Romanet V., Müller A., Murakami M., Radimerski T., Bentires-Alj M. Cancer Cell 2012, 22:796-811. this issue.
3. Chakrabarty A., Sánchez V., Kuba M.G., Rinehart C., Arteaga C.L. Proc. Natl. Acad. Sci. USA 2012, 109:2718-2723.
4. Deretic V., Jiang S., Dupont N. Trends Cell Biol. 2012, 22:397-406.
5. Hanahan D., Weinberg R.A. Cell 2011, 144:646-674.
6. Ibrahim Y.H., García-García C., Serra V., He L., Torres-Lockhart K., Prat A., Anton P., Cozar P., Guzmán M., Grueso J., et al. Cancer Discov 2012, 2:1036-1047.
7. Muranen T., Selfors L.M., Worster D.T., Iwanicki M.P., Song L., Morales F.C., Gao S., Mills G.B., Brugge J.S. Cancer Cell 2012, 21:227-239.
8. Seavey M.M., Dobrzanski P. Biochem. Pharmacol. 2012, 83:1136-1145.
9. Vanhaesebroeck B., Stephens L., Hawkins P. Nat. Rev. Mol. Cell Biol. 2012, 13:195-203.
10. Waugh D.J., Wilson C. Clin. Cancer Res. 2008, 14:6735-6741.